Quetmolimab: A Deep Dive into KANAb 001 and E-6011 The molecule, E-6011, is a promising approach targeting programmed cell death protein 1. First clinical results from these studies, KANAb 001 and E-6011, demonstrate https://www.targetmol.com/compound/quetmolimab